Enalapril

This classification denotes an ace inhibitor with the molecular formula C20H28N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69PN84IO1A, chemically known as l-proline, n-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl- but generally known as enalapril, which bears US NIH Compound Identifier 5362032. European Medicines Agency schedules Enalapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06514MIG. The term ENALAPRIL is an International Non-Proprietary Name. World Health Organization schedules enalapril in its Anatomical Therapeutic Chemical (ATC) Classification. ENALAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule enalapril under HS 29339990 and SITC 51577. As of Q4 2014, ENALAPRIL remains the US FDA Preferred Term for this commodity. Enalapril bears US NLM identifiers UMLS ID C0014025 and NCI Concept Code C62027. SMILES: O=C(N1C(CCC1)C(=O)O)C(NC(CCc1ccccc1)C(=O)OCC)C.